VELCADE Data at EHA 2014 Highlight Efficacy in Newly-Diagnosed Mantle Cell Lymphoma and Reinforce Its Role as a Backbone of Multiple Myeloma Therapy

30-07-2014 Business Wire HealthComments (0)

Velcade

VELCADE Data at EHA 2014 Highlight Efficacy in Newly-Diagnosed Mantle Cell Lymphoma and Reinforce Its Role as a Backbone of Multiple Myeloma Therapy.

Read more on Business Wire Health

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top